Loading...

UNITY BIOTECHNOLOGY INC Business Restructuring 8-K Filing

NTY

UNITY BIOTECHNOLOGY INC

()

2025 8-K

Lease Termination

Company Dissolution

Rights Offerings

Management Changes

Voluntary Delisting

Voluntary Delisting

Management Changes

Q1 Financial Results

Director Resignation

Board Appointment

Financial Results

Management Change

Q3 Financial Results

Earnings Reports

Annual Meeting of Stockholders

Earnings Reports

Financial Results Announcement

Restatement of Financial St...

Earnings Report

Entry into Material Definit...

Announcement of Study Results

Termination of Loan Agreement

Earnings Reports

Annual Meeting of Stockholders

Financial Results Announcement

Positive Data Announcement

Departure of Directors or C...

Amendment to Sales Agreement

Financial Results Announcement

Awareness of Bank Closure

External Links:

On September 18, 2025, Unity Biotechnology, Inc. shareholders approved the liquidation and dissolution of the company, with 450 million votes in favor and 150 million against. The company's common stock was previously delisted from Nasdaq on August 16, 2025, and now trades on the OTC market under the symbol 'UNBX.'

AI Assistant

UNITY BIOTECHNOLOGY INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.